chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported "numbness" on back portion of tongue about 2 min after vaccine administered. No swelling of lips/tongue or oral mucosa seen. Vital signs WNL and stable. No other signs/symptoms noted. Issue resolved spontaneously after about 1/2 hour. No sequelae reported.
fever; chills; Left deltoid/arm tenderness; Lymph node swelling/Swollen Lymphnodes in R axilla; pain around the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MYALGIA (Left deltoid/arm tenderness), LYMPHADENOPATHY (Lymph node swelling/Swollen Lymphnodes in R axilla) and VACCINATION SITE PAIN (pain around the injection site) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Cholesterol and Diabetes. Concurrent medical conditions included Coronary artery disease on 04-Jan-2004. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) from 01-Jan-2015 to an unknown date for Antiplatelet therapy, ACETYLSALICYLIC ACID (BABY ASPIRIN) from 01-Jan-2004 to an unknown date for Coronary artery disease, METFORMIN from 01-Jan-2010 to an unknown date for Diabetes mellitus, PRAVASTATIN from 01-Jan-2004 to an unknown date and EVOLOCUMAB from 01-Jan-2018 to an unknown date for Hyperlipidemia, METOPROLOL for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced MYALGIA (Left deltoid/arm tenderness), LYMPHADENOPATHY (Lymph node swelling/Swollen Lymphnodes in R axilla) and VACCINATION SITE PAIN (pain around the injection site). In January 2021, MYALGIA (Left deltoid/arm tenderness) had resolved. On 10-Apr-2021, LYMPHADENOPATHY (Lymph node swelling/Swollen Lymphnodes in R axilla) had resolved. At the time of the report, VACCINATION SITE PAIN (pain around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Ipatient received a steroid injection in lateral sides of both upper legs due to bilateral greater trochanteric bursitis. given to him by an orthopedic surgeon (this was unrelated to the swollen LN). The lymph nodes disappeared and tenderness went away after that by April 10th, 2021.  he is not sure if the systemic absorption of the local steroid injections helped dissolve the lymph nodes.   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2021: Made changes as per follow-up1. updated the current medical condition (CAD)2. updated the concomitant medications, their dates, dosage, indications of use3. updated the outcome of events from unknown to Recovered/Resolved along with the dates provided 4. added to the Inarrative supplement
The day following vax pt developed a fever of 102F and an injection site reaction at the site of Pnu-Imune-23 administration which the reporter did not describe. On 12/7/00 pt was seen by MD and treated with Motrin, Benadryl, Tylenol and applications of cold compresses. A copy of this report has been forwarded to Aventis Pasteur Inc., manufacturer of Fluzone. Follow-up info recvd 6/18/01 indicated that the pt received Pnu-Imune 23 on 12/6/00. He recovered.
2 months after patient's 2nd Covid-19 booster shot: altered sense of taste.  Foods tasted bland.  More salt needed to be added.   PCP was notified.  No treatment offered.  Symptoms still come and go.
feels weak; felt warm; he could not stay awake; fatigue and tired; pain in his lower abdomen; Could not sleep last night because the pain was so bad; little dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (pain in his lower abdomen), ASTHENIA (feels weak), FEELING HOT (felt warm), DIZZINESS (little dizzy) and SOMNOLENCE (he could not stay awake) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 5AW1-U56-MH22) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced DIZZINESS (little dizzy). On 14-Mar-2021, the patient experienced ABDOMINAL PAIN LOWER (pain in his lower abdomen) and INSOMNIA (Could not sleep last night because the pain was so bad). On 15-Mar-2021, the patient experienced ASTHENIA (feels weak), FEELING HOT (felt warm), SOMNOLENCE (he could not stay awake) and FATIGUE (fatigue and tired). At the time of the report, ABDOMINAL PAIN LOWER (pain in his lower abdomen), ASTHENIA (feels weak), FEELING HOT (felt warm), DIZZINESS (little dizzy), SOMNOLENCE (he could not stay awake) and FATIGUE (fatigue and tired) had not resolved and INSOMNIA (Could not sleep last night because the pain was so bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Reportedly, the patient could not sleep because the pain in his lower abdomen was very bad.
3/26/2021 - Approximately 20 minutes after the injection I started having tingling in my right hand.  Same side as injection.  I started having tingling and itchy gums itchy throat and itchy ears.  My throat swelled up on both sides.  All of the above in mild form.  I was still sitting in my car in the parking lot & remained there for an additional 30 minutes to make sure it did not get worse.  I subsequently ate lunch and continued with my day.  Around 9:45pm I went to bed and found that when I would lie down I experienced increased difficulty in swallowing as neck was still swollen both sides under ears and around jaw line.  At 10:00pm I took 1 single 25mg  Benadryl tablet.  Swelling subsided noticeably within 20 minutes.  The following day (3/27/2021) much improved with only slight swelling on the left side of my throat under my left ear and along jaw line.  Right arm sore from shoulder down to my wrist.  By the end of the day my arm was no longer sore.  Left side of my throat was still slightly swollen.  At bedtime I took 1/2 of a 25 mg Benadryl tablet.  Felt fine on Sunday however i still feel as if i have slight swelling
Information has been received from a physician concerning a 14 year old female who on 14-AUG-2007 was vaccinated with her first 0.5ml dose of Gardasil (lot# unspecified).  Concomitant therapy included MENACTRA and Tdap.  It was reported that after receiving her first dose of Gardasil the patient had swollen tonsils.  Unspecified medical attention was sought.  The patient's swollen tonsils persisted.  No further information was provided.  Additional information has been requested.
Atrial fibrillation; emergency room admission; 4-day hospitalization; CAT scan; ECG; Colonoscopy; Start Eliquis;  Transesophageal Echocardiography; Cardioversion. release date: 04/05/2022. Cardiologist Doctor follow-up set for 04/25/2022.
Patient's arm is red, sore, puffy, warm to the touch and extremely painful.  Symptoms presented within 24 hours and has gotten worse over the past 2 days.
lt arm felt heavy per pt p/receiving shot then 5 mins later c/o tingling on lt side; 2 hrs later lt arm sore & feels heavy no tingling reported;
mild headache at waking up and during the day on and off sweats on and off chills on and off  feeling unwell as if I will get a flu or heavy cold
Slightly less than 3 months after receiving the second Shringrix injection, I came down with Shingles. The rash location was pubic/pelvic/buttocks--right side--and about 4 weeks after onset of initial symptoms I developed PHN: numbness on right buttock, running down right leg and especially affecting foot. Left foot also developed some sympathetic numbness. About 4-5 weeks after onset of PHN, it began to recede.
Post herpetic neuralgia; Herpes zoster; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided.  On an unknown date, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) for routine health maintenance and prevention of shingles (herpes zoster).   On an unknown date (reported as "shortly after receiving vaccine"), the patient suffered from multiple bouts of herpes zoster and post-herpetic neuralgia. As a result of these symptoms, the patient was seen and treated by medical providers.  It was reported that the patient's symptoms had resulted in physical limitations not present prior to used zoster vaccine live (ZOSTAVAX). Further, the patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of the patient's condition. Also, the patient suffered serious, progressive, permanent and incurable injuries as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the patient's conduct, patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  At the time of the report, the outcome of shingles and post-herpetic neuralgia was reported as not recovered/not resolved.    Upon internal review, shingles were considered to be disabling due to permanent and incurable injuries.  The reporter considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).
Left arm swelling and pain, persistent for 1 week at this time, associated myalgias, conjunctivitis, and fatigue
This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 60-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included Influenza vaccine 2017-2018 season for an unknown indication. On 14th December 2018, the patient received the 2nd dose of SHINGRIX and Influenza vaccine 2017-2018 season. On 17th December 2018, 3 days after receiving SHINGRIX and Influenza vaccine 2017-2018 season, the patient experienced shoulder pain, leg pain and headache. On an unknown date, the patient experienced vaccine administered at inappropriate site. On an unknown date, the outcome of the shoulder pain, leg pain and headache were not recovered/not resolved and the outcome of the vaccine administered at inappropriate site was unknown. It was unknown if the reporter considered the shoulder pain, leg pain and headache to be related to SHINGRIX and Influenza vaccine 2017-2018 season. Additional details were provided as follows: SHINGRIX dose was administered way up on the backside of the patient's right arm, which led to inappropriate site administration; and the Flu vaccine was administered in the patient's left arm. The patient was experiencing excruciating pain in his right shoulder and down his left leg. The patient had an MRI performed but had not received the results yet. The patient had been prescribed a muscle relaxer but was hesitant to take it. The patient was 5 feet 9 and half and weighs 160 pounds. The patient could normally do multiple sets of pushups but could not do 1 at a time. Lab Comments: Lab test performed on unknown date and result not received yet.
administered Kinrix vaccine instead of separate DTaP and IPV vaccines; administered Kinrix vaccine instead of separate DTaP and IPV vaccines; This case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 11-month-old male patient who received DTPa-IPV (Kinrix) (batch number E2L54, expiry date 3rd March 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 19th November 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 19th November 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that, the patient was inadvertently administered Kinrix vaccine instead of separate DTaP and IPV vaccines which led to inappropriate age at vaccine administration and wrong vaccine administered. The nurse stated the physician had spoken with child's parent who reported that, infant has not had any side effects. The reporter consented to follow up.
This spontaneous report as received from a registered nurse refers to 10 patients of unknown age and gender. On an unknown date those patients were inadvertently vaccinated with MMR II (albumin status, dose, units, route of administration, anatomical location, lot number were not reported) that had been improperly stored. No adverse effects reported. Additional information is not expected because the reporter refused to be contacted.
1st Moderna booster made her end up in the hospital; This spontaneous case was reported by a patient and describes the occurrence of HOSPITALISATION (1st Moderna booster made her end up in the hospital) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis.     The patient's past medical history included Seizures.    On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced HOSPITALISATION (1st Moderna booster made her end up in the hospital) (seriousness criterion hospitalization). At the time of the report, HOSPITALISATION (1st Moderna booster made her end up in the hospital) outcome was unknown.            No concomitant medications were reported.  She mentioned that the first Moderna booster made her end up in the hospital; 2nd booster was advised by her doctor to prevent seizures; 3rd booster was successful.  Company Comment This spontaneous case concerns an elderly female patient with medical history of Seizures who experienced the seriousness criteria hospitalization unexpected event of hospitalization unknown days after SPIKEVAX NOS vaccine. She mentioned that the first Moderna booster made her end up in the hospital; 2nd booster was advised by her doctor to prevent seizures; 3rd booster was successful. The benefit-risk relationship of SPIKEVAX NOS vaccine is not affected by this report.   No treatment medications were provided.
4MAY92 recvd 1st dose of Engerix-B & w/in 24 hrs devel nausea, fatigue, diarrhea, & dizziness; no treatment given;
Soreness; consumer just took her temp about five minutes ago and it was little bit higher than it was, initially, it was like 101 point consumer wanted to say 2/fever was slightly higher than it was earlier; Nausea; Chills; Headache; This is a spontaneous report from a contactable consumer. This consumer reported for a 15-year-old female patient (Reporter's daughter). A 15-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection) via an unspecified route of administration on 17Jul2021 (Lot Number: EW0171) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection) on an unknown date for covid 19 immunization. Patient just took her second dose of the vaccine yesterday (17Jul2021) and this morning (18Jul2021), she experienced some soreness, a fever and nausea and consumer have given her some medication, she ate, she did take some Tylenol (treatment) and she rested. Then, consumer just took her temp about five minutes ago and it was little bit higher than it was, initially, it was like 101 point consumer wanted to say 2 (event captured as per verbatim). When paraphrased the concern, reporter stated that It was for his daughter. After she took the Tylenol, this was earlier in the morning, this morning (sentence incomplete). Reporter further stated, that his concern was what to do for her fever, some hours later, we were off in to the night, it was about 5 minutes to 10 her time. Her fever was slightly higher than it was earlier that morning when she took the Tylenol (treatment). They were just trying to get some advice on what they need to do because they were concerned that she was still having the fever and she also experienced some chills as well and nausea and headache on 18Jul2021. Consumer understood those were the side effects but they were trying to see, was this normal or did she need to see her pediatrician. Expiration date: Reporter stated that did not have an expiration date on here, he just have the card. Reporter was informed about Pfizer Medical Information department and provided with the number. Further probing could not be initiated reporter hung up the call abruptly. Hence, other details were unknown and limited information was available over the call. Outcome of the event, consumer just took her temp about five minutes ago and it was little bit higher than it was, initially, it was like 101 point consumer wanted to say 2/fever was slightly higher than it was earlier was not recovered while for other events was unknown.
(R) arm - swollen & red - saw Dr. & treated with BENADRYL.
RED AND HOT no hives just blotches slightly raised; Rash on face and neck, chest and ears; RED AND HOT no hives just blotches slightly raised; RED AND HOT no hives just blotches slightly raised; This is a spontaneous report from a contactable consumer or other non-health care professional reported for patient. A non-pregnant female patient of 36-year-old received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: not reported), via an unspecified route of administration, administered in Arm Left on 18Mar2021 16:45 (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. Medical history included Crohn's disease, seasonal allergy, food allergy. The patient's concomitant medications were not reported. Patient received unspecified medication in two weeks.The patient previously took gluten and experienced drug hypersensitivity. Patient did not received any other vaccine within four weeks of COVID-19. Patient was not diagnosed with COVID-19 prior to vaccination. Patient was not tested for COVID since vaccination. On an unspecified date in 2021, the patient experienced red and hot no hives just blotches slightly raised, rash on face and neck, chest and ears, red and hot no hives just blotches slightly raised. No treatment was received due to adverse events. Patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: not reported), via an unspecified route of administration, administered in Arm Left on 08Apr2021 16:45 as dose 2, single for COVID-19 immunization and experienced adverse events. The outcome of the event was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (loss of appetite). At the time of the report, DECREASED APPETITE (loss of appetite) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications were reported  No treatment medications were reported   Reporter did not allow further contact
Patient had ED visit 30 days after receiving COVID dose #3.  Patient was admitted to hospital 31 days after receiving COVID dose #3.  Patient passed away 56 days after receiving COVID dose #3.
pt recv vax 15OCT96 & rash, itching, red bumps began 20OCT96;spread over entire body-still having diff but less;began mild nerve med for gen itching approx 1mo ago (no rash);seen by MD & dermatology;given med;8NOV96 still bumps;
Patient presented to the ED on 3/19/2021 and was subsequently admitted within 6 weeks of receiving COVID vaccination.
Patient was given the Pfizer vaccine on 1/27/2021 (left deltoid, lot#:EL3248) and should have had the Pfizer second dose on 2/17/2021. Patient was inadvertently given the Moderna vaccine.
Rash and soreness at injection site, body aches and pain (moderate-severe), nausea, malaise.
Hives over entire body, projectile vomiting, copious amounts of mucous coming from nose, labored breathing
Beginning on 1/5 at 8 am Fever 101, body aches chills. (expected reaction), however over the course of the next 3 days,  short of breath with minimal exertion, increased heart rate to 150 with minimal movement.  Resolved symptoms on 1/10.
Pt had intense abdominal pain; dx with appendectomy,  surgery found metastatic colon cancer required HIPEC chemo surgery
Redness, swelling, pain at injection site; chills, body aches, nausea, high fever 101.6 - 101.8; headache, stuffy head, lethargy; most symptoms abated by 2nd day after injection, however headache and  fever remained and was even higher.  I am still on my 2nd day after injection and feeling absolutely horrible. I WILL NOT BE GETTING THE 2ND DOSE!!!
Swelling, redness, warmth, pain, hives that covered entire arm that vaccine was given in.
Pain in Left arm; Cannot move the left arm/cannot raise up the hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in Left arm) and HYPOKINESIA (Cannot move the left arm/cannot raise up the hand) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in Left arm) and HYPOKINESIA (Cannot move the left arm/cannot raise up the hand). At the time of the report, PAIN IN EXTREMITY (Pain in Left arm) and HYPOKINESIA (Cannot move the left arm/cannot raise up the hand) outcome was unknown.            No concomitant medications were reported.   No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: TCR form received on 28-JUN-2021 included no new information.
pt recv vax NOV98 & hair loss cont;11DEC98 pt noticed a grayish cloud in vision lt eye for several hr; examined by ophthalmologist and found to be ok;18JAN99 exp distortion in peripheral vision of lt eye,  dx:vein occlusion near optic nerve
This spontaneous report as received from a certified medical assistant (healthcare worker) refers to a 12 month old patient of unknown gender. On 11-NOV-2014 the patient was vaccinated with M-M-R II (subcutaneously, 0.5 ml dose, frequency reported as once, lot # reported as J004321) that was expiry dated on 17-OCT-2014. No adverse effects reported. Lot # J004321 is an invalid lot # for M-M-R II. Additional information has been requested.